{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:06:19Z","timestamp":1789016779234,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1989,12,1]],"date-time":"1989-12-01T00:00:00Z","timestamp":628473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1989,12,1]],"date-time":"1989-12-01T00:00:00Z","timestamp":628473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Oncol. &amp; Tumor Pharmacother."],"published-print":{"date-parts":[[1989,12]]},"DOI":"10.1007\/bf02985158","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T18:21:13Z","timestamp":1631902873000},"source":"Crossref","is-referenced-by-count":14,"title":["Variability of 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute leukemia"],"prefix":"10.1007","volume":"6","author":[{"given":"Pierre","family":"Lafolie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Bj\u00f6rk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Hayder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"\u00c5hstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curt","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02985158_CR1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.V8.11.965.965","volume":"8","author":"J H Burchenal","year":"1953","unstructured":"Burchenal J H, Murphy M L, Ellison R R: Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of acute leukemia and allied disease.Blood\n                           8, 965 (1953).","journal-title":"Blood"},{"key":"BF02985158_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V56.1.1.1","volume":"56","author":"A M Mauer","year":"1980","unstructured":"Mauer A M: Therapy of acute lymphoblastic leukemia in childhood.Blood\n                           56, 1 (1980).","journal-title":"Blood"},{"key":"BF02985158_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/1097-0142(19860715)58:2+<473::AID-CNCR2820581311>3.0.CO;2-0","volume":"58","author":"D G Poplack","year":"1986","unstructured":"Poplack D G, Balis F M, Zimm S: The pharmacology of orally administered chemotherapy: a reappraisal.Cancer\n                           58, 473 (1986).","journal-title":"Cancer"},{"key":"BF02985158_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0006-2952(63)90012-1","volume":"12","author":"G B Elion","year":"1963","unstructured":"Elion G B, Callahan S, Nathan H, Bieber S, Rundles R, Hitchings G H: Potentiation by inhibition of drug degradation: 6-substituted purines and xanthine oxidase.Biochem Pharmac\n                           12, 85 (1963).","journal-title":"Biochem Pharmac"},{"key":"BF02985158_CR5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJM198304283081705","volume":"308","author":"S Zimm","year":"1983","unstructured":"Zimm S, Collins J M, Riccardi R, O\u2019Neil D, Narang P K, Chabner B, Poplack D B: Variable bioavailability of oral mercaptopurine.New Engl J Med\n                           308, 1005 (1983a).","journal-title":"New Engl J Med"},{"key":"BF02985158_CR6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/clpt.1986.178","volume":"40","author":"L Lennard","year":"1986","unstructured":"Lennard L, Keen D, Lilleyman J S: Oral 6-mercaptopurine in childhood leukemia: parent drug pharmacokinetics and active metabolite concentrations.Clin Pharmac Ther\n                           40, 287 (1986).","journal-title":"Clin Pharmac Ther"},{"key":"BF02985158_CR7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/clpt.1984.177","volume":"36","author":"E S Vasell","year":"1984","unstructured":"Vasell E S: Complex effects of diet on drug disposition.Clin Pharmac Ther\n                           36, 285 (1984).","journal-title":"Clin Pharmac Ther"},{"key":"BF02985158_CR8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S0140-6736(80)92105-4","volume":"ii","author":"C R Pinkerton","year":"1980","unstructured":"Pinkerton C R, Welshman S G, Glasgow J F, Bridges J M: Can food influence the absorption of methotrexate in children with acute lymphoblastic leukemia?Lancet\n                           ii, 944 (1980).","journal-title":"Lancet"},{"key":"BF02985158_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0009-9120(86)80052-2","volume":"19","author":"W Kalow","year":"1986","unstructured":"Kalow W: Genetics of drug transformation.Clin Biochem\n                           19, 76 (1986).","journal-title":"Clin Biochem"},{"key":"BF02985158_CR10","first-page":"21","volume":"242","author":"J A van Loon","year":"1987","unstructured":"van Loon J A, Weinshilboum R M: Human lymphocyte thiopurine methyltransferase pharmacogenetics: effects of fenotype on 6-mercaptopurine-induced inhibition of mitogen stimulation.J Pharmac exp Ther\n                           242, 21 (1987).","journal-title":"J Pharmac exp Ther"},{"key":"BF02985158_CR11","first-page":"36","volume-title":"Basic and Clinical Pharmacology","author":"M A Correira","year":"1987","unstructured":"Correira M A, Castagnoli N Jr: Pharmacokinetics: II. Drug biotransformation, in Katzung B G (ed):Basic and Clinical Pharmacology, 3rd edn, p. 36. Los Altos, CA, Lange (1987).","edition":"3rd edn"},{"key":"BF02985158_CR12","first-page":"169","volume":"214","author":"F Sj\u00f6qvist","year":"1986","unstructured":"Sj\u00f6qvist F, Bertilsson L: Slow hydroxylation of tricyclic antidepressants \u2014 relationship to polymorphic drug oxidation.Prog clin Biol Res\n                           214, 169 (1986).","journal-title":"Prog clin Biol Res"},{"key":"BF02985158_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1651-2227.1986.tb10293.x","volume":"75","author":"P Lafolie","year":"1986","unstructured":"Lafolie P, Hayder S, Bjork O, \u00c5hstr\u00f6m L, Liliemark J, Peterson C: Large interindividual variations in the pharmacokinetics of oral 6-mercaptopurine in maintenance therapy of children with acute leukaemia and non-Hodgkin lymphoma.Acta Paediatr scand\n                           75, 797 (1986).","journal-title":"Acta Paediatr scand"},{"key":"BF02985158_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/08880018609031198","volume":"33","author":"G L\u00f6nnerholm","year":"1986","unstructured":"L\u00f6nnerholm G, Kreuger A, Lindstr\u00f6m B, Ludvigsson J, Myrdal U: Plasma and erythrocytic concentrations of mercaptopurine after oral administration in children.Pediatr Hemat Oncol\n                           33, 27 (1986).","journal-title":"Pediatr Hemat Oncol"},{"key":"BF02985158_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2165\/00003088-198409020-00006","volume":"9","author":"L A Bauer","year":"1984","unstructured":"Bauer L A, Gilbaldi M, Westal R E: Influence of pharmacokinetic diurnal variation on bioavailability estimates.Clin Pharmacokinet\n                           9, 184 (1984).","journal-title":"Clin Pharmacokinet"},{"key":"BF02985158_CR16","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0140-6736(85)91551-X","volume":"ii","author":"G E Rivard","year":"1985","unstructured":"Rivard G E, Infante-Rivard O, Hoyox O, Champagne J: Maintenance chemotherapy for childhood acute lymphoblastic leukemia: better in the evening.Lancet\n                           ii, 1264 (1985).","journal-title":"Lancet"},{"key":"BF02985158_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(87)91808-3","volume":"ii","author":"A M Langevin","year":"1987","unstructured":"Langevin A M, Koren G, Soldin S J, Greenberg M: Pharmacokinetic case for giving 6-mercaptopurine maintenance doses at night.Lancet\n                           ii, 505 (1987).","journal-title":"Lancet"},{"key":"BF02985158_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3109\/08880018609031233","volume":"3","author":"R Riccardi","year":"1986","unstructured":"Riccardi R, Balis F, Ferrasa P, Lasorella A, Poplack D, Mastrangelo R: Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.Pediatr Hemat Oncol\n                           3, 319 (1986).","journal-title":"Pediatr Hemat Oncol"},{"key":"BF02985158_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/BF00253074","volume":"18","author":"N Burton","year":"1986","unstructured":"Burton N, Barnett M, Aherne G, Evans J, Douglas I, Lister T: The effect of food on the oral administration of 6-mercaptopurine.Cancer Chemother Pharmac\n                           18, 90 (1986).","journal-title":"Cancer Chemother Pharmac"},{"key":"BF02985158_CR20","first-page":"15","volume":"35","author":"L Lennard","year":"1983","unstructured":"Lennard L, Maddocks J L: Assay of 6-thioguanine nucleotide, a major metabolite of azathioprine, 6-mercaptopurine and 6-thioguanine in human red blood cells.J Pharmac\n                           35, 15 (1983).","journal-title":"J Pharmac"},{"key":"BF02985158_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0192-0561(86)90067-6","volume":"8","author":"B Odlind","year":"1986","unstructured":"Odlind B, Hartvig P, Lindstrom B, Lonnerholm G, Tufveson G. Grefberg N: Serum azathioprine and 6-mercaptopurine levels and immunosuppressive activity after azathioprine in uremic patients.Int J Immunopharmac\n                           8, 1 (1986).","journal-title":"Int J Immunopharmac"},{"key":"BF02985158_CR22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/clpt.1987.45","volume":"41","author":"F M Balis","year":"1987","unstructured":"Balis F M, Holcenberg J S, Zimm S, Tubergen D, Collins J M, Murphy R F, Gilchrist G S, Hammond D, Poplack D G: The effect of methotrexate on the bioavailability of oral 6-mercaptopurine.Clin Pharmac Ther\n                           41, 384 (1987).","journal-title":"Clin Pharmac Ther"},{"key":"BF02985158_CR23","first-page":"195","volume":"195 B","author":"J P Bokkerink","year":"1984","unstructured":"Bokkerink J P, de Abreu R, van Laarhoven J, Bakker M, Hulscher T W, Schretlen E, de Bruijn C: Increased bioavailability of phosphoribosyl pyrophosphate as the basis for enhanced 6-mercaptopurine incorporation by methotrexate, in cultured human lymphoblasts.Adv exp Med Biol\n                           195 B, 195 (1984).","journal-title":"Adv exp Med Biol"},{"key":"BF02985158_CR24","first-page":"738","volume":"34","author":"D M Tidd","year":"1974","unstructured":"Tidd D M, Paterson A R P: A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine.Cancer Res\n                           34, 738 (1974).","journal-title":"Cancer Res"},{"key":"BF02985158_CR25","first-page":"297","volume":"27","author":"S Zimm","year":"1986","unstructured":"Zimm S, Johnson G E, Poplack D G: Modulation of thiopurine cytotoxicity by physiologic concentrations of hypoxanthine.Proc Am Ass Cancer Res\n                           27, 297 (1986).","journal-title":"Proc Am Ass Cancer Res"},{"key":"BF02985158_CR26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cpt196892180","volume":"9","author":"T L Loo","year":"1968","unstructured":"Loo T L, Luke J L, Sullivan M P, Frei E III: Clinical pharmacologic observations on 6-mercaptopurine and 6-methylthiopurine ribonucleoside.Clin Pharmac Ther\n                           9, 180 (1968).","journal-title":"Clin Pharmac Ther"},{"key":"BF02985158_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0378-4347(00)85171-3","volume":"336","author":"J M van Baal","year":"1984","unstructured":"van Baal J M, van Leeuwen M B, Schouten T J, de Abreu R A: Sensitive high-performance liquid chromatografic determination of 6-mercaptopurine, 6-thioguanine, 6-mercaptopurine riboside and 6-thioguanoside in biological fluids.J Chromatogr\n                           336, 422 (1984).","journal-title":"J Chromatogr"},{"key":"BF02985158_CR28","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/0003-2697(85)90148-4","volume":"144","author":"L E Lavi","year":"1985","unstructured":"Lavi L E, Holcenberg J S: A rapid and sensitive high-performance liquid chromatografic assay for 6-mercaptopurine metabolites in red blood cells.Analyt Biochem\n                           144, 514 (1985).","journal-title":"Analyt Biochem"},{"key":"BF02985158_CR29","first-page":"888","volume":"26","author":"G B Elion","year":"1967","unstructured":"Elion G B: Biochemistry and pharmacology of purine analogues.Fedn Proc\n                           26, 888 (1967).","journal-title":"Fedn Proc"},{"key":"BF02985158_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1172\/JCI111068","volume":"72","author":"M E King","year":"1983","unstructured":"King M E, Honeysett J M, Howell S B B: Regulation ofde novo purine synthesis in human bone marrow mononuclear cells by hypoxanthine.J clin Invest\n                           72, 965 (1983).","journal-title":"J clin Invest"},{"key":"BF02985158_CR31","first-page":"649","volume":"647","author":"P G W Plageman","year":"1981","unstructured":"Plageman P G W, Marz R, Wohlhueter R M, Graff J C, Zylka J M: Facilitated transport of 6-mercaptopurine and 6-thioguanine and non-mediated permeation of 8-azaguanine in Novikoff rat hepatoma ceils and relationship to intracellular phosphoribosylation.Biochem biophys Acta\n                           647, 649 (1981).","journal-title":"Biochem biophys Acta"},{"key":"BF02985158_CR32","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0006-2952(84)90238-7","volume":"83","author":"W R Ravis","year":"1984","unstructured":"Ravis W R, Wang J S, Feldmann S: Intestinal absorption and metabolism of 6-mercaptopurine in the rat small intestine.Biochem Pharmac\n                           83, 443 (1984).","journal-title":"Biochem Pharmac"},{"key":"BF02985158_CR33","first-page":"87","volume":"12","author":"O A Rees","year":"1984","unstructured":"Rees O A, Lennard L, Lilleyman J S, Maddocks J L: Disturbance of 6-mercaptopurine metabolism by cotrimoxazole in childhood lymphoblastic leukemia.Cancer Chemother Pharmac\n                           12, 87 (1984).","journal-title":"Cancer Chemother Pharmac"},{"key":"BF02985158_CR34","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/clpt.1983.254","volume":"34","author":"S Zimm","year":"1983","unstructured":"Zimm S, Collins J M, O\u2019Neil D, Chabner B A, Poplack D G: Inhibition of first pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol.Clin Pharmac Ther\n                           34, 810 (1983b).","journal-title":"Clin Pharmac Ther"},{"key":"BF02985158_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0006-2952(75)90124-0","volume":"24","author":"M C Kong","year":"1975","unstructured":"Kong M C, Parks R E Jr: Incorporation of the purine moieties of guanosine and inosine analogs into nucleotide pools of human erythrocytes.Biochem Pharmac\n                           24, 807 (1975).","journal-title":"Biochem Pharmac"},{"key":"BF02985158_CR36","first-page":"4156","volume":"45","author":"S Zimm","year":"1985","unstructured":"Zimm S, Johnson G E, Chabner B A, Poplack D G: Cellular pharmacokinetics of mercaptopurine in human neoplastic cells and cell lines.Cancer Res\n                           45, 4156 (1985).","journal-title":"Cancer Res"},{"key":"BF02985158_CR37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/bjc.1986.16","volume":"53","author":"L Lennard","year":"1986","unstructured":"Lennard L, Lilleyman J S, Maddocks J L: The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukemia.Br J Cancer\n                           53, 115 (1986).","journal-title":"Br J Cancer"},{"key":"BF02985158_CR38","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/0016-5085(87)90564-6","volume":"93","author":"N S Leleiko","year":"1987","unstructured":"Leleiko N S, Martin B A, Walsh M, Kazcow P, Rabinowitz S, Sterling K: Tissuespecific gene expression results from a purine and pyrimidinefree diet and 6-mercaptopurine in the rat small intestine and colon.Gastroenterology\n                           93, 1014 (1987).","journal-title":"Gastroenterology"},{"key":"BF02985158_CR39","unstructured":"Hayder S, Lafolie P, Bj\u00f6rk O, \u00c5hstr\u00f6m L, Peterson C: Pharmacokinetics and influence of food on oral 6-mercaptopurine in maintenance therapy in children with acute lymphoblastic leukemia.Proc Int Soc Paediatr Oncol,320 (1985)."},{"key":"BF02985158_CR40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/clpt.1988.78","volume":"43","author":"C A Arndt","year":"1988","unstructured":"Arndt C A, Balis F M, McCully C L, Jeffries S L, Doherty K, Murphy R, Poplack D G: Bioavailability of low-dose vs high-dose 6-mercaptopurine.Clin Pharmac Ther\n                           43, 588 (1988).","journal-title":"Clin Pharmac Ther"},{"key":"BF02985158_CR41","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1016\/0006-2952(84)90026-1","volume":"24","author":"S Zimm","year":"1984","unstructured":"Zimm S, Grygiel J J, Strong J M, Monks TJ, Poplack D G: Identification of 6-mercaptopurine riboside in patients receiving 6-mercaptopurine as a prolonged intravenous infusion.Biochem Pharmac\n                           24, 4089 (1984).","journal-title":"Biochem Pharmac"},{"key":"BF02985158_CR42","first-page":"1869","volume":"45","author":"S Zimm","year":"1985","unstructured":"Zimm S, Ettinger L J, Holcenberg J Set al. Phase 1 and clinical pharmacological study of mercaptopurine administered as a prolonged intravenous infusion.Cancer Res\n                           45, 1869 (1985).","journal-title":"Cancer Res"},{"key":"BF02985158_CR43","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/clpt.1986.233","volume":"40","author":"H Sulh","year":"1986","unstructured":"Sulh H, Koren G, Whalen C, Soldin S, Zipursky A, Greenberg M: Pharmacokinetic determinants of 6-mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia.Clin Pharmac Ther\n                           40, 604 (1986).","journal-title":"Clin Pharmac Ther"}],"container-title":["Medical Oncology and Tumor Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02985158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02985158\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02985158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T19:15:38Z","timestamp":1631906138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02985158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,12]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,12]]}},"alternative-id":["BF02985158"],"URL":"https:\/\/doi.org\/10.1007\/bf02985158","relation":{},"ISSN":["0736-0118"],"issn-type":[{"value":"0736-0118","type":"print"}],"subject":[],"published":{"date-parts":[[1989,12]]},"article-number":"259"}}